ロード中...
Progress and Challenges Associated with the Development of Ricin Toxin Subunit Vaccines
The past several years have seen major advances in the development of a safe and efficacious ricin toxin vaccine, including the completion of two Phase I clinical trials with two different recombinant A subunit (RTA)-based vaccines: RiVax™ and RVEc™ adsorbed to aluminum salt adjuvant, as well as a n...
保存先:
| 出版年: | Expert Rev Vaccines |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5193006/ https://ncbi.nlm.nih.gov/pubmed/26998662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14760584.2016.1168701 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|